EUCTR2015-002499-26-FR进行中（未招募）1 期
Tranexamic acid to reduce blood loss in hemorrhagic caesarean delivery: a multicenter randomized double blind placebocontrolled dose ranging study - TRACES
Centre Hospitalier Régional et Universitaire de Lille0 个研究点目标入组 342 人开始时间: 2015年9月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 342
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •-Each patient experiencing a bleeding volume of more than 800 mL during an elective or emergent caesarean section
- •-Patient covered by social security
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patient unable to consent and/or <18 years old and/or legally assisted (incapable people or specially protected mentioned on the article L1121-5 to L1121-8 will not be included in the study).
- •Previous deep vein thrombosis or seizures or any contraindication to tranexamic acid
- •Inherited haemorrhagic diseases, essentially the Von Willbebrand disease
- •Patient presenting with a severe Hellp syndrome (platelet count <50 000/m3) or renal failure prior to the caesarean section (RIFLE score>2)
- •Administration of TA before inclusion
研究者
相似试验
进行中（未招募）
1 期
Tranexamic Acid to reduce bleeding in patients treated with new oral anticoagulants undergoing dental extraction (EXTRACT-NOAC)Patients treated with a NOAC, aged 18 years or older undergoing dental extractionEUCTR2017-001426-17-BEniversity Hospitals Leuven (Gasthuisberg)222
进行中（未招募）
不适用
Transamin's benefit in decreasing blood loss in knee prosthesis patientsTranexamic acidhemorrhageblood transfusionblood volumeD02.241.223.268.860C23.550.414E02.095.135G09.188.130RBR-4dvhtsFundacao Hospital Adriano Jorge
已完成
2 期
Efficacy of tranexamic acid in reducing blood loss in patients with placenta accrete spectrumPlacenta accretaIRCT20201003048909N1Ahvaz University of Medical Sciences23
进行中（未招募）
1 期
Research about the administration of an intravenous drug (trantexamic acid)in order to reduce the amount of trasnsfusion in patients suffering femur fracture. An experiment involving patients is designed: two groups of patients are created by chance allocation, in one the tranexamic acid is administered and in the other an innert substance. After that we compare the amount of blood cell bags needed.Bleeding in patients suffering femur neck fractureMedDRA version: 20.1Level: LLTClassification code 10053220Term: Hip injurySystem Organ Class: 100000004863EUCTR2018-000528-32-ESConsorci Mar Parc de Salut de Barcelona (Parc de Salut Mar)276
已完成
不适用
Tranexamic acid for prevention of bleeding at caesarean sectioSurgerybleeding at caesarean sectionPACTR201706002304422federal teaching hospital abakaliki120